EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 40 (Novembre 2024) Hors série n° 1 Med Sci (Paris), 40 (2024) 40-44 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 40, Novembre 2024
Les Cahiers de Myologie
Page(s) 40 - 44
Section Prix SFM
DOI https://doi.org/10.1051/medsci/2024129
Publié en ligne 18 novembre 2024
  1. Johnson NE, Butterfield RJ, Mayne K, et al. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program. Neurology 2021 ; 96 : e1045–e1053. [PubMed] [Google Scholar]
  2. Overend G, Légaré C, Mathieu J, et al. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet 2019 ; 28 : 2245–2254. [CrossRef] [PubMed] [Google Scholar]
  3. De Antonio M, Dogan C, Hamroun D, et al. Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification. Rev Neurol (Paris) 2016 ; 172 : 572–580. [CrossRef] [PubMed] [Google Scholar]
  4. Ravel-Chapuis A, Duchesne E, Jasmin BJ. Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients. J Physiol 2022 ; 600 : 3249–3264. [CrossRef] [PubMed] [Google Scholar]
  5. Dahlqvist JR, Ørngreen MC, Witting N, Vissing J. Endocrine function over time in patients with myotonic dystrophy type 1. Eur J Neurol 2015 ; 22 : 116–122. [CrossRef] [PubMed] [Google Scholar]
  6. Severinsen MCK, Pedersen BK. Muscle–Organ Crosstalk: The Emerging Roles of Myokines. Endocr Rev 2020 ; 41 : 594–609. [CrossRef] [PubMed] [Google Scholar]
  7. Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol Rev Camb Philos Soc 2021 ; 96 : 716–730. [CrossRef] [PubMed] [Google Scholar]
  8. Grande V, Hathazi D, O’Connor E, et al. Dysregulation of GSK3β-target proteins in skin fibroblasts of Myotonic Dystrophy Type 1 (DM1) patients. J Neuromuscul Dis 2021 ; 8 : 603–619. [CrossRef] [PubMed] [Google Scholar]
  9. Brockhoff M, Rion N, Chojnowska K, et al. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I. J Clin Invest 2017 ; 127 : 549–563. [CrossRef] [PubMed] [Google Scholar]
  10. Ravel-Chapuis A, Al-Rewashdy A, Bélanger G, et al. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles. Hum Mol Genet 2018 ; 27 : 3361–3376. [CrossRef] [PubMed] [Google Scholar]
  11. Steinberg GR, Hardie DG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 2023 ; 24 : 255–272. [CrossRef] [PubMed] [Google Scholar]
  12. Theret M, Gsaier L, Schaffer B, et al. AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis. EMBO J 2017 ; 36 : 1946–1962. [CrossRef] [PubMed] [Google Scholar]
  13. Kneppers A, Ben Larbi S, Theret M, et al. AMPKα2 is a skeletal muscle stem cell intrinsic regulator of myonuclear accretion. iScience 2023 ; 26 : 108343. [CrossRef] [PubMed] [Google Scholar]
  14. Misquitta NS, Ravel-Chapuis A, Jasmin BJ. Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner. Hum Mol Genet 2023 ; 32 : 551–566. [CrossRef] [PubMed] [Google Scholar]
  15. Todorow V, Hintze S, Kerr ARW, et al. Transcriptome analysis in a primary human muscle cell differentiation model for myotonic dystrophy type 1. Int J Mol Sci 2021 ; 22 : 8607. [CrossRef] [PubMed] [Google Scholar]
  16. Mikhail AI, Manta A, Ng SY, et al. A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1. Acta Physiol (Oxf) 2023 ; 237 (4) : e13943. [CrossRef] [PubMed] [Google Scholar]
  17. García-Puga M, Saenz-Antoñanzas A, Fernández-Torrón R, et al. Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin. Aging (Albany NY) 2020 ; 12 : 6260–6275. [CrossRef] [PubMed] [Google Scholar]
  18. Di Leo V, Lawless C, Roussel MP, et al. Resistance exercise training rescues mitochondrial dysfunction in skeletal muscle of patients with myotonic dystrophy type 1. J Neuromuscul Dis 2023 ; 10 : 1111–1126. [CrossRef] [PubMed] [Google Scholar]
  19. Zhao H, Li T, Wang K, et al. AMPK-mediated activation of MCU stimulates mitochondrial Ca2+ entry to promote mitotic progression. Nat Cell Biol 2019 ; 21 : 476–486. [CrossRef] [PubMed] [Google Scholar]
  20. Renna LV, Bosè F, Brigonzi E, et al. Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies. PLoS One 2019 ; 14 : e0214254. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.